327.87
前日終値:
$337.27
開ける:
$336.79
24時間の取引高:
195.81K
Relative Volume:
0.53
時価総額:
$7.45B
収益:
-
当期純損益:
$-518.67M
株価収益率:
-13.05
EPS:
-25.12
ネットキャッシュフロー:
$-438.32M
1週間 パフォーマンス:
-4.02%
1か月 パフォーマンス:
-2.34%
6か月 パフォーマンス:
+54.34%
1年 パフォーマンス:
+22.78%
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
名前
Madrigal Pharmaceuticals Inc
セクター
電話
404-380-9263
住所
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
MDGL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MDGL
Madrigal Pharmaceuticals Inc
|
327.87 | 7.45B | 0 | -518.67M | -438.32M | -25.12 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-28 | アップグレード | B. Riley Securities | Neutral → Buy |
2025-02-27 | 繰り返されました | H.C. Wainwright | Buy |
2024-06-28 | 開始されました | Cantor Fitzgerald | Neutral |
2024-06-11 | 開始されました | Wolfe Research | Outperform |
2024-04-22 | 開始されました | BofA Securities | Underperform |
2024-03-15 | アップグレード | B. Riley Securities | Sell → Neutral |
2024-03-06 | 開始されました | Citigroup | Buy |
2024-02-26 | ダウングレード | B. Riley Securities | Neutral → Sell |
2022-12-20 | 繰り返されました | Oppenheimer | Outperform |
2022-12-19 | 繰り返されました | H.C. Wainwright | Buy |
2022-12-19 | 繰り返されました | Piper Sandler | Overweight |
2022-12-19 | アップグレード | Raymond James | Underperform → Mkt Perform |
2022-07-08 | ダウングレード | B. Riley Securities | Buy → Neutral |
2021-10-07 | 開始されました | Jefferies | Buy |
2021-08-06 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2021-05-20 | 再開されました | Goldman | Buy |
2020-11-24 | 再開されました | Evercore ISI | Outperform |
2020-11-06 | 繰り返されました | H.C. Wainwright | Buy |
2020-07-31 | 開始されました | Piper Sandler | Overweight |
2020-06-05 | 開始されました | BMO Capital Markets | Market Perform |
2020-05-05 | 開始されました | Chardan Capital Markets | Buy |
2020-01-30 | 開始されました | Canaccord Genuity | Buy |
2020-01-09 | アップグレード | UBS | Neutral → Buy |
2019-11-07 | 繰り返されました | H.C. Wainwright | Buy |
2019-06-25 | 開始されました | Stifel | Hold |
2019-06-10 | アップグレード | B. Riley FBR | Neutral → Buy |
2019-02-28 | 繰り返されました | H.C. Wainwright | Buy |
2019-02-22 | 開始されました | SVB Leerink | Outperform |
2019-01-23 | 開始されました | UBS | Neutral |
2018-12-14 | 開始されました | Wolfe Research | Outperform |
2018-12-12 | 開始されました | B. Riley FBR | Neutral |
2018-11-19 | ダウングレード | Raymond James | Mkt Perform → Underperform |
2018-11-16 | アップグレード | Evercore ISI | In-line → Outperform |
2018-09-04 | 開始されました | Citigroup | Buy |
2018-08-06 | ダウングレード | Goldman | Buy → Neutral |
2018-06-28 | 開始されました | Raymond James | Mkt Perform |
すべてを表示
Madrigal Pharmaceuticals Inc (MDGL) 最新ニュース
Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March? - Yahoo Finance
Madrigal (MDGL) Up 0.5% Since Last Earnings Report: Can It Continue? - Nasdaq
Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long - Simply Wall St
(MDGL) On The My Stocks Page - Stock Traders Daily
EU health regulator clears use of AI tool in fatty liver disease trials - Reuters
Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires - Insider Monkey
15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey
Madrigal Pharmaceuticals Announces Changes to Board of Directors - MSN
Madrigal Pharmaceuticals SVP and CFO sells stock for $83,344 - Investing.com India
Madrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potential By Investing.com - Investing.com Australia
Madrigal Pharmaceuticals’ SWOT analysis: Rezdiffra success drives stock potential - Investing.com India
Madrigal Pharmaceuticals SVP and CFO sells stock for $83,344 By Investing.com - Investing.com Australia
Victory Capital Management Inc. Has $21.80 Million Stock Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World
Bank of New York Mellon Corp Lowers Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World
Madrigal Pharmaceuticals appoints new board member By Investing.com - Investing.com Australia
How the (MDGL) price action is used to our Advantage - Stock Traders Daily
Madrigal Pharmaceuticals Expands Board with New Appointment - TipRanks
Madrigal appoints Jacqualyn Fouse to its board -March 11, 2025 at 09:36 am EDT - Marketscreener.com
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. To Board - citybiz
Madrigal Pharmaceuticals appoints new board member - Investing.com India
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors - The Manila Times
Why Madrigal Pharmaceuticals (MDGL) Stock is Rising Today - GuruFocus.com
Robert E. Waltermire Sells 14,113 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock - Defense World
Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, - GuruFocus.com
Madrigal Pharmaceuticals Exec Cashes Out in Multi-Million Dollar Stock Sale! - TipRanks
Madrigal Pharmaceuticals’ senior VP sells $4.8 million in stock By Investing.com - Investing.com Canada
Madrigal Pharmaceuticals’ senior VP sells $4.8 million in stock - Investing.com India
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Holdings Reduced by Principal Financial Group Inc. - Defense World
Madrigal Pharmaceuticals CFO Mardi sells $637,247 in stock - Investing.com India
Madrigal Pharmaceuticals exec sells $418,488 in stock By Investing.com - Investing.com South Africa
Madrigal Pharmaceuticals exec sells $418,488 in stock - Investing.com
Madrigal Pharmaceuticals (NASDAQ:MDGL) Trading Down 6.8% on Insider Selling - Defense World
B. Riley Analysts Increase Earnings Estimates for MDGL - Defense World
Sanctuary Advisors LLC Acquires 62 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - Defense World
HC Wainwright Issues Negative Estimate for MDGL Earnings - Defense World
Madrigal Pharmaceuticals Reports Strong 2024 Growth Fueled by Rezdiffra Launch - MSN
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives $351.67 Consensus PT from Analysts - MarketBeat
New York State Common Retirement Fund Sells 5,630 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) - MarketBeat
Citigroup Boosts Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $469.00 - Defense World
Madrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat
Madrigal Pharmaceuticals director Kenneth Bate sells $7.1m in stock By Investing.com - Investing.com Australia
(MDGL) Trading Report - Stock Traders Daily
Madrigal Pharmaceuticals director Kenneth Bate sells $7.1m in stock - Investing.com
Citigroup Issues Positive Forecast for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price - MarketBeat
Madrigal Pharmaceuticals Inc (MDGL) 財務データ
収益
当期純利益
現金流量
EPS
Madrigal Pharmaceuticals Inc (MDGL) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
CRAVES FRED B | Director |
Mar 13 '25 |
Option Exercise |
65.06 |
7,742 |
503,695 |
357,818 |
CRAVES FRED B | Director |
Mar 12 '25 |
Sale |
331.84 |
7,728 |
2,564,426 |
350,076 |
CRAVES FRED B | Director |
Mar 13 '25 |
Sale |
325.25 |
7,742 |
2,518,053 |
350,076 |
大文字化:
|
ボリューム (24 時間):